iTeh StandardsiTeh Standards
EURUSD
Your shopping cart is empty.
SIST

SIST EN ISO 15225:2000/A2:2005

(Amendment)

Nomenclature - Specification for a nomenclature system for medical devices for the purpose of regulatory data exchange (ISO 15225:2000/Amd 1:2004)

Nomenclature - Specification for a nomenclature system for medical devices for the purpose of regulatory data exchange (ISO 15225:2000/Amd 1:2004)

This European Standard specifies requirements and guidance for the construction of a nomenclature for medical devices in order to facilitate co-operation and exchange of regulatory data on an international level between interested parties such as: Regulatory Authorities, Manufacturers, Suppliers, Health Care Providers, and End Users. NOTE: This European Standard includes guidelines for a minimum data set and its structure. These guidelines are provided for system designers setting up databases utilizing the nomenclature system described herein.

Nomenklatur - Spezifikation für ein Nomenklatursystem für Medizinprodukte zum Zweck des regulativen Datenaustauschs (ISO 15225:2000/Amd 1:2004)

Nomenclature - Spécifications pour un systeme de nomenclature des dispositifs médicaux destiné a l'échange de données réglementaires (ISO 15225:2000/Amd 1:2004)

Poimenovanje – Specifikacija za sistem poimenovanja medicinskih pripomočkov za obvezno izmenjavo podatkov (ISO 15225:2000/Amd 1:2004)

General Information

Status
Withdrawn
Publication Date
31-Aug-2005
Withdrawal Date
26-Aug-2010
ICS
11.040.01 - Medical equipment in general
35.240.80 - IT applications in health care technology
Technical Committee
VAZ - Healthcare
Current Stage
9900 - Withdrawal (Adopted Project)
Start Date
27-Aug-2010
Due Date
19-Sep-2010
Completion Date
27-Aug-2010
Directive
93/42/EEC - Council Directive 93/42/EEC of 14 June 1993 concerning medical devices
98/79/EC - Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices
Ref Project
EN ISO 15225:2000/A2:2005 - Nomenclature - Specification for a nomenclature system for medical devices for the purpose of regulatory data exchange (ISO 15225:2000/Amd 1:2004)

Relations

Replaced By
SIST EN ISO 15225:2010 - Medical devices - Quality management - Medical device nomenclature data structure (ISO 15225:2010)
Effective Date
01-Oct-2010
Amends
SIST EN ISO 15225:2000 - Nomenclature - Specification for a nomenclature system for medical devices for the purpose of regulatory data exchange (ISO 15225:2000)
Effective Date
22-Dec-2008
Amends
SIST EN ISO 15225:2000 - Nomenclature - Specification for a nomenclature system for medical devices for the purpose of regulatory data exchange (ISO 15225:2000)
Effective Date
08-Jun-2022

Buy Standard

EN ISO 15225:2000/A2:2005EN ISO 15225:2000/A2:2005
PreviousNext
Amendment
EN ISO 15225:2000/A2:2005
English language
6 pages
sale 10% off
Preview
sale 10% off
Preview
e-Library read for
1 day

Standards Content (Sample)

SLOVENSKI STANDARD
SIST EN ISO 15225:2000/A2:2005
01-september-2005
3RLPHQRYDQMH±6SHFLILNDFLMD]DVLVWHPSRLPHQRYDQMDPHGLFLQVNLKSULSRPRþNRY
]DREYH]QRL]PHQMDYRSRGDWNRY ,62$PG
Nomenclature - Specification for a nomenclature system for medical devices for the
purpose of regulatory data exchange (ISO 15225:2000/Amd 1:2004)
Nomenklatur - Spezifikation für ein Nomenklatursystem für Medizinprodukte zum Zweck
des regulativen Datenaustauschs (ISO 15225:2000/Amd 1:2004)
Nomenclature - Spécifications pour un systeme de nomenclature des dispositifs
médicaux destiné a l'échange de données réglementaires (ISO 15225:2000/Amd
1:2004)
Ta slovenski standard je istoveten z: EN ISO 15225:2000/A2:2005
ICS:
11.040.01 Medicinska oprema na Medical equipment in general
splošno
35.240.80 Uporabniške rešitve IT v IT applications in health care
zdravstveni tehniki technology
SIST EN ISO 15225:2000/A2:2005 en
2003-01.Slovenski inštitut za standardizacijo. Razmnoževanje celote ali delov tega standarda ni dovoljeno.

---------------------- Page: 1 ----------------------

SIST EN ISO 15225:2000/A2:2005

---------------------- Page: 2 ----------------------

SIST EN ISO 15225:2000/A2:2005
EUROPEAN STANDARD
EN ISO 15225:2000/A2
NORME EUROPÉENNE
EUROPÄISCHE NORM
July 2005
ICS 11.040.01; 35.240.80
English version
Nomenclature - Specification for a nomenclature system for
medical devices for the purpose of regulatory data exchange
(ISO 15225:2000/Amd 1:2004)
Nomenclature - Spécifications pour un système de Nomenklatur - Spezifikation für ein Nomenklatursystem für
nomenclature des dispositifs médicaux destiné à l'échange Medizinprodukte zum Zweck des regulativen
de données réglementaires (ISO 15225:2000/Amd 1:2004) Datenaustauschs (ISO 15225:2000/Amd 1:2004)
This amendment A2 modifies the European Standard EN ISO 15225:2000; it was approved by CEN on 27 June 2005.
CEN members are bound to comply with the CEN/CENELEC Internal Regulations which stipulate the conditions for inclusion of this
amendment into the relevant national standard without any alteration. Up-to-date lists and bibliographical references concerning such
national standards may be obtained on application to the Central Secretariat or to any CEN member.
This amendment exists in three official versions (English, French, German). A version in any other language made by translation under the
responsibility of a CEN member into its own language and notified to the Central Secretariat has the same status as the official versions.
CEN members are the national standards bodies of Austria, Belgium, Cyprus, Czech Republic, Denmark, Estonia, Finland, France,
Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Slovakia,
Slovenia, Spain, Sweden, Switzerland and United Kingdom.
EUROPEAN COMMITTEE FOR STANDARDIZATION
COMITÉ EUROPÉEN DE NORMALISATION
EUROPÄISCHES KOMITEE FÜR NORMUNG
Management Centre: rue de Stassart, 36  B-1050 Brussels
© 2005 CEN All rights of exploitation in any form and by any means reserved Ref. No. EN ISO 15225:2000/A2:2005: E
worldwide for CEN national Members.

---------------------- Page: 3 ----------------------

SIST EN ISO 15225:2000/A2:2005
EN ISO 15225:2000/A2:2005 (E)


Foreword
This document (EN 15225:2000/A2:2005) has been prepared by Technical Committee
CEN/TC 257 “Symbols and information provided with medical devices and nomenclature for
regulatory data exchange”, the secretariat of which is held by SFS.
This European Standard shall be given the status of a national standard, either by publication of
an identical text or by endorsement, at the latest by January 2006, and conflicting national
standards shall be withdrawn at the latest by January 2006.
This document has been prepared under a mandate given to CEN by the European Commission
and the European Free Trade Association, and supports essential requirements of EU
Directive(s).
For relationship with EU Directive(s), see informative Annex ZC, which is an integral part of this
document.
According to the CEN/CENELEC Internal Regulations, the national standards organizations of the
following countries are bound to implement this European Standard: Austria, Belgium, Cyprus,
Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland,
Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal,
Slovakia, Slovenia, Spain, Sweden, Switzerland and United Kingdom.


Endorsement notice

The text of ISO 15225:2000/Amd 1:2004 has been approved by CEN as EN ISO 15225:2000/
A2:2005 without any modifications.
2

---------------------- Page: 4 ----------------------

SIST EN ISO 15225:2000/A2:2005
EN ISO 15225:2000/A2:2005 (E)
Contents

At the end of the existing table of contents in EN ISO 15225:2000, insert the following new entry:

Annex ZC (informative) Relationship between this European Standard and the Essential
Requirements of Directive 98/79/EC

Add the following Annex ZC.

3

---------------------- Page: 5 ----------------------

SIST EN ISO 15225:2000/A2:2005
EN ISO 15225:2000/A2:2005 (E)


Annex ZC
(informative)

Relationship between this European Standard and the Essential
Requirements of Directive 98/79/EC

This European Standard has been prepared under a mandate given to CEN by the European
Commission and the European Free Trade Association to provide a means of conforming to
Essential Requirements of the New Approach Directive 98/79/EC.

Once this standard is cited in the Official Journal of the European Communities under that
Directive and has been implemented as a national standard in at least one Member State,
compliance with the normative clauses of this standard given in Table ZC.1 confers, within the
limits of the scope of this standard, a presumption of conformity with the corresponding Essential
Requirements of that Directive and associated EFTA regulations.
WARNING: Other requirements and other EU Directives may be applicable to the product(s)
falling within the scope of this standard.
Table ZC.1 - Correspondence between this European Standard and Directive 98/79/EC
Clause(s)/Sub-clause(s) of this European Essential requirements (ERs) from Qualifying Remarks /Notes
Standard Council Directive on in vitro
diagnostic medical devices
(98/79/EC)

6.2, 6.3, 6.4, 6.5 Article 4, Clause 4
This standard Article 8, Clause 3
This standard Article 9, Clause 4
This standard Article 10, Clauses 1, 2, 4, 5, 6
This standard Article 11, Clauses 1, 2, 3
This standard Article 12, Clauses 1,2, 3
This standard Article 14, Clauses 1, 2, 3
This standard Article 15, Clauses 5, 6
This standard Annex I, Clause B.8.4 b)
This standard Annex I, Clause B.8.7 a)
This standard Annex I, Clause B.8.7.m
This standard, 5.3, 6 Annex III
...

Questions, Comments and Discussion

Ask us and Technical Secretary will try to provide an answer. You can facilitate discussion about the standard in here.

This May Also Interest You

SIST
SIST EN IEC 81001-5-1:2022(Main)
Health software and health IT systems safety, effectiveness and security - Part 5-1: Security - Activities in the product life cycle (IEC 81001-5-1:2021)
EN IEC 81001-5-1:2022

1.1 Purpose
This document defines the LIFE CYCLE requirements for development and maintenance of HEALTH SOFTWARE needed to support conformity to IEC 62443-4-1 - taking the specific needs for HEALTH SOFTWARE into account. The set of PROCESSES, ACTIVITIES, and TASKS described in this document establishes a common framework for secure HEALTH SOFTWARE LIFE CYCLE PROCESSES.
[Fig. 1]
The purpose is to increase the information SECURITY of HEALTH SOFTWARE by establishing certain ACTIVITIES and TASKS in the HEALTH SOFTWARE LIFE CYCLE PROCESSES and also by increasing the SECURITY of SOFTWARE LIFE CYCLE PROCESSES themselves.
It is important to maintain an appropriate balance of the key properties SAFETY, effectiveness and SECURITY as discussed in IEC 81001-1.
This document excludes specification of ACCOMPANYING DOCUMENTATION contents.
1.2 Field of application
This document applies to the development and maintenance of HEALTH SOFTWARE by a MANUFACTURER, but recognizes the critical importance of bi-lateral communication with organizations (e.g. HDOs) who have SECURITY responsibilities for the HEALTH SOFTWARE and the systems it is incorporated into, once the software has been developed and released. The IEC/ISO 81001-5 series of standards (for which this is part 1, is therefore being designed to include future parts addressing SECURITY that apply to the implementation, operations and use phases of the LIFE CYCLE for organizations such as HDOs.
Medical device software is a subset of HEALTH SOFTWARE. Therefore, this document applies to:
− Software as part of a medical device;
− Software as part of hardware specifically intended for health use;
− Software as a medical device (SaMD); and
− Software-only PRODUCT for other health use.
Note: In this document, the scope of software considered part of the LIFE CYCLE ACTIVITIES for secure HEALTH SOFTWARE is larger and includes more software (drivers, platforms, operating systems) than for SAFETY, because for SECURITY the focus will be on any use including foreseeable unauthorized access rather than just the INTENDED USE.
[Fig. 2]
1.3 Conformance
HEALTH SOFTWARE conformance with this document is defined as implementing all of the PROCESSES, ACTIVITIES, and TASKS identified in the normative parts of this document - with the exception of Annex F.
Conformance of TRANSITIONAL HEALTH SOFTWARE with Annex F of this document is defined as only implementing the PROCESSES, ACTIVITIES, and TASKS identified in Annex F of this document.
Conformance is determined by inspection and establishing traceability of the PROCESSES, ACTIVITIES and TASKS required.
The quality management system may be implemented according to ISO 13485 or other equivalent quality management system standards.
IEC 62304 specifies ACTIVITIES, based on the software SAFETY classification. The required ACTIVITIES are indicated in the normative text of IEC 62304 as "[Class A, B, C]", "[Class B, C]" or "[Class C]", indicating that they are required selectively depending on the classification of the software to which they apply. The requirements in this document have a special focus on information SECURITY and therefore do not follow the concept of SAFETY classes. For conformity to this document the selection of ACTIVITIES is independent of SAFETY classes.
Implementing the PROCESSES, ACTIVITIES and TASKS specified in this document is sufficient to implement the PROCESS requirements of IEC 62443-4-1. MANUFACTURERS may implement the specifications for Annex E in order to achieve full conformity to IEC 62443-4-1.
This document requires establishing one or more PROCESSES that comprise of identified ACTIVITIES. The LIFE CYCLE PROCESSES shall implement these ACTIVITIES. None of the requirements in this document requires to implement these ACTIVITIES as one single PROCESS or as separate PROCESSES. The ACTIVITIES specified in this document will typically be part of an existing LIFE CYCLE PROCESS.

  • Standard
    59 pages
    English language
    sale 10% off
    e-Library read for
    1 day
SIST
SIST EN IEC 80001-1:2022(Main)
Application of risk management for IT-networks incorporating medical devices - Part 1: Safety, effectiveness and security in the implementation and use of connected medical devices or connected health software (IEC 80001-1:2021)
EN IEC 80001-1:2021

This document specifies general requirements for ORGANIZATIONS in the application of RISK
MANAGEMENT before, during and after the connection of a HEALTH IT SYSTEM within a HEALTH IT
INFRASTRUCTURE, by addressing the KEY PROPERTIES of SAFETY, EFFECTIVENESS and SECURITY
whilst engaging appropriate stakeholders.

  • Standard
    39 pages
    English language
    sale 10% off
    e-Library read for
    1 day
SIST
SIST EN ISO 11073-10418:2014/AC:2017(Corrigendum)
Health informatics - Personal health device communication - Part 10418: Device specialization - International Normalized Ratio (INR) monitor - Technical Corrigendum 1 (ISO/IEEE 11073-10418:2014/Cor 1:2016)
EN ISO 11073-10418:2014/AC:2016

ISO corr

  • Corrigendum
    20 pages
    English language
    sale 10% off
    e-Library read for
    1 day
SIST
SIST EN ISO 11073-10418:2014(Main)
Health informatics - Personal health device communication - Part 10418: Device specialization: International Normalized Ratio (INR) monitor (ISO 11073-10418:2014, Corrected version 2014-05-01)
EN ISO 11073-10418:2014

The scope of this standard is to establish a normative definition of communication between personal telehealth International Normalized Ratio (INR) devices (agents) and managers (e.g. cell phones, personal computers, personal health appliances, and set top boxes) in a manner that enables plug-and-play interoperability. It leverages work done in other ISO/IEEE 11073 standards including existing terminology, information profiles, application profile standards, and transport standards. It specifies the use of specific term codes, formats, and behaviors in telehealth environments restricting optionality in base frameworks in favor of interoperability. This standard defines a common core of functionality of INR devices. In the context of personal health devices, INR monitoring refers to the measurement of the prothrombin time (PT) that is used to assess the level of anticoagulant therapy and its presentation as the International Normalized Ratio compared to the prothrombin time of normal blood plasma. Applications of the INR monitor include the management of the therapeutic level of anticoagulant used in the treatment of a variety of conditions. This standard provides the data modeling and its transport shim layer according to IEEE Std 11073-20601aTM-2010 and does not specify the measurement method.

  • Standard
    76 pages
    English language
    sale 10% off
    e-Library read for
    1 day
  • Standard
    76 pages
    English language
    sale 10% off
    e-Library read for
    1 day
SIST
SIST EN 80001-1:2011
Application of risk management for IT-networks incorporating medical devices - Part 1: Roles, responsibilities and activities (IEC 80001-1:2010)
EN 80001-1:2011

Recognizing that MEDICAL DEVICES are incorporated into IT-NETWORKS to achieve desirable benefits (for example, INTEROPERABILITY), this international standard defines the roles, responsibilities and activities that are necessary for RISK MANAGEMENT of IT-NETWORKS incorporating MEDICAL DEVICES to address SAFETY, EFFECTIVENESS and DATA AND SYSTEMSECURITY (the KEY PROPERTIES). This international standard does not specify acceptable RISK levels.
NOTE 1 The RISK MANAGEMENT activities described in this standard are derived from those in ISO 14971 [4]. The relationship between ISO 14971 and this standard is described in Annex A.
This standard applies after a MEDICAL DEVICE has been acquired by a RESPONSIBLE ORGANIZATION and is a candidate for incorporation into an IT-NETWORK.
NOTE 2 This standard does not cover pre-market RISK MANAGEMENT.
This standard applies throughout the life cycle of IT-NETWORKS incorporating MEDICAL DEVICES.
NOTE 3 The life cycle management activities described in this standard are very similar to those of
ISO/IEC 20000-2 [10]. The relationship between ISO/IEC 20000-2 and this standard is described in Annex D.
This standard applies where there is no single MEDICAL DEVICE manufacturer assuming responsibility for addressing the KEY PROPERTIES of the IT-NETWORK incorporating a MEDICAL
DEVICE.
NOTE 4 If a single manufacturer specifies a complete MEDICAL DEVICE that includes a network, the installation or assembly of the MEDICAL DEVICE according to the manufacturer’s ACCOMPANYING DOCUMENTS is not subject to the provisions of this standard regardless of who installs or assembles the MEDICAL DEVICE.
NOTE 5 If a single manufacturer specifies a complete MEDICAL DEVICE that includes a network, additions to that MEDICAL DEVICE or modification of the configuration of that MEDICAL DEVICE, other than as specified by the manufacturer, is subject to the provisions of this standard.
This standard applies to RESPONSIBLE ORGANIZATIONS, MEDICAL DEVICE manufacturers and
providers of other information technology for the purpose of RISK MANAGEMENT of an ITNETWORK incorporating MEDICAL DEVICES as specified by the RESPONSIBLE ORGANIZATION.
This standard does not apply to personal use applications where the patient, OPERATOR and RESPONSIBLE ORGANIZATION are one and the same person.
NOTE 6 In cases where a MEDICAL DEVICE is used at home under the supervision or instruction of the provider, that provider is deemed to be the RESPONSIBLE ORGANIZATION. Personal use where the patient acquires and uses a MEDICAL DEVICE without the supervision or instruction of a provider is out of scope of this standard. This standard does not address regulatory or legal requirements.

  • Standard
    44 pages
    English language
    sale 10% off
    e-Library read for
    1 day
SIST
SIST-TP CEN/TR 12349:2023(Main)
Mechanical vibration - Guide to the health effects of vibration on the human body
CEN/TR 12349:2023

The aim of this CEN report is to provide information on the possible adverse health effects caused by exposure to vibration at work.  the report addresses manufacturers as well as employers and employees using vibrating machinery in order to improve their understanding of the possible health problems arising from occupational exposure to vibration.

  • Technical report
    17 pages
    English language
    sale 10% off
    e-Library read for
    1 day
SIST
SIST EN ISO 80004-1:2023(Main)
Nanotechnologies - Vocabulary - Part 1: Core vocabulary (ISO 80004-1:2023)
EN ISO 80004-1:2023

This document defines core terms in the field of nanotechnology. This document is intended to facilitate communication between organizations and individuals in industry and those who interact with them.

  • Standard
    24 pages
    English language
    sale 10% off
    e-Library read for
    1 day
  • Draft
    25 pages
    English language
    sale 10% off
    e-Library read for
    1 day
SIST
SIST EN ISO 3262-4:2023(Main)
Extenders - Specifications and methods of test - Part 4: Whiting (ISO 3262-4:2022)
EN ISO 3262-4:2023

This document specifies requirements and corresponding methods of test for whiting.

  • Standard
    11 pages
    English language
    sale 10% off
    e-Library read for
    1 day
  • Draft
    9 pages
    English language
    sale 10% off
    e-Library read for
    1 day
SIST
SIST EN ISO 1247-1:2023(Main)
Aluminium pigments for paints - Part 1: General aluminium pigments (ISO 1247-1:2021)
EN ISO 1247-1:2023

This document specifies the requirements and corresponding test methods for aluminium pigments suitable for use in paints including:
a) general, decorative and protective paints, and
b) special finishing paints.

  • Standard
    33 pages
    English language
    sale 10% off
    e-Library read for
    1 day
  • Draft
    30 pages
    English language
    sale 10% off
    e-Library read for
    1 day
SIST
SIST EN ISO 18473-4:2023(Main)
Functional pigments and extenders for special applications - Part 4: Nanoscale titanium dioxide for photocatalytic application (ISO 18473-4:2022)
EN ISO 18473-4:2023

This document specifies requirements and corresponding test methods for nanoscale titanium dioxide (TiO2) in either powder or suspension form for photocatalytic application.
This document is applicable to modified nanoscale titanium dioxide for photocatalytic application. Such modification can be surface treatment, coating, doping and combination thereof.

  • Standard
    13 pages
    English language
    sale 10% off
    e-Library read for
    1 day
  • Draft
    10 pages
    English language
    sale 10% off
    e-Library read for
    1 day